Design Therapeutics Sets IPO Offering Range
socalTECH
MARCH 23, 2021
Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 The company has applied to list on the Nasdaq Global Market as DSGN. The IPO offering would net the company around $276M, and value it at over $1.1 and $20.00
Let's personalize your content